Chong Kun Dang wins patent suit against Novartis over immunosuppressant Korea Biomedical Review
Chong Kun Dang said it has won the lawsuit against Novartis over the patent of Novartis’ immunosuppressant Certican (ingredient: everolimus).
Chong Kun Dang wins patent suit against Novartis over immunosuppressant Korea Biomedical Review
Chong Kun Dang said it has won the lawsuit against Novartis over the patent of Novartis’ immunosuppressant Certican (ingredient: everolimus).